– USA, PA – Windtree Therapeutics, Inc. (Nasdaq: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases, announced the appointment of Leanne Kelly to its Board as an independent director, effective immediately.
“We are excited to welcome Leanne to Windtree’s Board of Directors. Her experience will enhance the strength of our Board as we launch our new corporate strategy to become a revenue-generating biotech by using Company equity to acquire small biotech companies struggling to maximize the commercial potential of their FDA-approved products. We look forward to sharing our progress as we execute this strategy,” said CEO, Jed Latkin.
Leanne Kelly joins the Audit Committee as Chair.
About Leanne Kelly
Leanne Kelly has served as CFO of GRI Bio since April 2023. She brings over 20 years of experience leading private and publicly traded companies across the life science, technology, and e-commerce sectors with a foundation in public accounting. Before joining GRI Bio, she was CFO of Vallon Pharmaceuticals from May 2021 to April 2023 and Controller and Executive Director of Global Financial Reporting at OptiNose, Inc. from 2016 to 2021. Earlier in her career, she held senior finance roles at Flower Orthopedics, Iroko Pharmaceuticals, and Genaera Corporation.
Leanne Kelly holds an undergraduate degree in business economics with a concentration in accounting from Lehigh University and is a licensed CPA in Pennsylvania.
About Windtree Therapeutics
Windtree Therapeutics, Inc. is a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions and diseases. Its portfolio includes istaroxime, a Phase II candidate with SERCA2a activating properties for acute heart failure and cardiogenic shock, preclinical SERCA2a activators for heart failure, and preclinical aPKCi inhibitors for rare and broad oncology applications. Windtree also has a licensing business model with partnership out-licenses currently in place.
For more, visit www.windtreetx.com.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.